KCNMA1
MOLECULAR TARGETpotassium calcium-activated channel subfamily M alpha 1
KCNMA1 (potassium calcium-activated channel subfamily M alpha 1) is targeted by 20 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting KCNMA1
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | pterostilbene | 1.10 | 2 |
| 2 | Nisoldipine | 1.10 | 2 |
| 3 | Perphenazine | 1.10 | 2 |
| 4 | Ritonavir | 1.10 | 2 |
| 5 | Budesonide | 0.69 | 1 |
| 6 | Amoxapine | 0.69 | 1 |
| 7 | Carvedilol | 0.69 | 1 |
| 8 | Fluocinolone Acetonide | 0.69 | 1 |
| 9 | Flutamide | 0.69 | 1 |
| 10 | Imatinib Mesylate | 0.69 | 1 |
| 11 | Latanoprost | 0.69 | 1 |
| 12 | Lovastatin | 0.69 | 1 |
| 13 | nafadotride | 0.69 | 1 |
| 14 | 3',4'-didemethylnobiletin [Supplementary Concept] | 0.69 | 1 |
| 15 | Nortriptyline | 0.69 | 1 |
| 16 | Promethazine | 0.69 | 1 |
| 17 | L 741519 [Supplementary Concept] | 0.69 | 1 |
| 18 | Thioridazine | 0.69 | 1 |
| 19 | Torsemide | 0.69 | 1 |
| 20 | Vecuronium Bromide Monoquaternary homolog of PANCURONIUM. | 0.69 | 1 |
About KCNMA1 as a Drug Target
KCNMA1 (potassium calcium-activated channel subfamily M alpha 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 20 compounds with documented KCNMA1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
KCNMA1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.